Literature DB >> 6137351

Comparison of gamma-glutamyltransferase and questionnaire test as alcohol indicators in different risk groups.

B Peterson, E Trell, H Kristenson.   

Abstract

gamma-Glutamyltransferase (gamma-GT) and a Malmö modification of the Michigan Alcoholism Screening Test (Mm-MAST) were compared in subsamples of a health screening population of urban middle aged males with characterized levels of alcohol consumption and in the total group of deaths 0-6 years after the screening investigation. The questionnaire was markedly superior to gamma-GT in identifying the alcohol consumption in the known alcoholics but not in the other study groups. gamma-GT may be indicative of alcohol related health disturbances and may be used in their early recognition and as biochemical feedback in their further treatment and control in individuals. It may therefore be of value particularly as an instrument in a programme aimed at prevention of alcohol-related health complications.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137351     DOI: 10.1016/0376-8716(83)90019-4

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  4 in total

Review 1.  Alcoholism: early diagnosis and intervention.

Authors:  J T Hays; W A Spickard
Journal:  J Gen Intern Med       Date:  1987 Nov-Dec       Impact factor: 5.128

2.  Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group.

Authors:  F Pintus; P Mascia
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

3.  Risk factors for premature death in middle aged men.

Authors:  B Petersson; E Trell; N C Henningsen; B Hood
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-28

4.  Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes.

Authors:  S Alkayyali; M Lajer; H Deshmukh; E Ahlqvist; H Colhoun; B Isomaa; P Rossing; L Groop; V Lyssenko
Journal:  Diabetologia       Date:  2012-10-31       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.